Macromolecular properties and end-group analysis of heparin isolated from bovine liver capsule.
Glycosaminoglycans were extracted from bovine liver capsule with 4 M-guanidinium chloride, resulting in solubilization of approx. 90% of the total uronic acid-containing polysaccharide of the tissue. The extracted polysaccharide was purified and fractionated by anion-exchange chromatography on DEAE-cellulose, density-gradient ultracentrifugation in CsCl and finally gel chromatography on Sepharose 4B. By using these procedures, the two major polysaccharide components, dermatan sulphate and heparin, which constituted 55 and 30% respectively of the total glycosaminoglycan content of the tissue, were separated from each other. Analysis of the macromolecular properties of the two polysaccharides showed that heparin existed exclusively as single polysaccharide chains, whereas dermatan sulphate occurred largely as a proteoglycan (protein content, 74% dry wt.). The purified heparin preparation was subjected to sedimentation-equilibrium ultracentrifugation, indicating a molecular weight of 8800. Analysis for neutral sugars (by g.l.c.) showed 0.1 residue of xylose and 0.2 residue of galactose/polysaccharide chain; serine amounted to 0.3 residue/polysaccharide chain. Reduction of the heparin with NaB3H4 resulted in incorporation of 3H, approximately corresponding to one reducible group/polysaccharide chain. The 3H-labelled sugar residue was liberated by a combination of acid hydrolysis and deaminative cleavage of the polysaccharide with HNO2; it was subsequently identified as an aldonic acid by paper electrophoresis. Most of the heparin chains thus contained a uronic acid residue in reducing position. It is suggested that heparin isolated from bovine liver capsule is a degradation product released from larger molecules by an endo-glycuronidase.
D000596:Amino Acids / Q000032:analysis; D000818:Animals; D001894:Borohydrides; D002417:Cattle; D003871:Dermatan Sulfate / Q000302:isolation & purification; D006025:Glycosaminoglycans / Q000302:isolation & purification*; D006493:Heparin / Q000032:analysis / Q000302:isolation & purification*; D066298:In Vitro Techniques; D008099:Liver / Q000032:analysis*; D008970:Molecular Weight; D011134:Polysaccharides / Q000032:analysis; D014574:Uronic Acids / Q000032:analysis
D000596:Amino Acids; D001894:Borohydrides; D006025:Glycosaminoglycans; D011134:Polysaccharides; D014574:Uronic Acids; D003871:Dermatan Sulfate; D006493:Heparin